Provided by Tiger Fintech (Singapore) Pte. Ltd.

Milestone Pharmaceuticals Inc.

2.41
+0.240011.06%
Pre-market: 2.480.0686+2.85%08:23 EDT
Volume:3.98M
Turnover:9.49M
Market Cap:128.58M
PE:-3.18
High:2.50
Open:2.23
Low:2.20
Close:2.17
Loading ...

Milestone Pharmaceuticals Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
Yesterday

Milestone Pharmaceuticals’ SEC Exemptions: Balancing Reduced Disclosure with Investor Confidence Risks

TIPRANKS
·
14 Mar

Milestone Pharmaceuticals: Q4 Earnings Snapshot

Associated Press Finance
·
13 Mar

Milestone Pharmaceuticals FY 2024 GAAP EPS $(0.67) Misses $(0.62) Estimate, Cash Balance Of $69.7M

Benzinga
·
13 Mar

Milestone Pharmaceuticals Inc: Q4 Shr Loss $-0.19

THOMSON REUTERS
·
13 Mar

Press Release: Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update

Dow Jones
·
13 Mar

Milestone Pharmaceuticals reports inducement grants under Nasdaq listing rule

TIPRANKS
·
04 Mar

TD Cowen Keeps Their Buy Rating on Milestone Pharmaceuticals (MIST)

TIPRANKS
·
02 Mar

Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Milestone Pharmaceuticals (MIST) and Personalis (PSNL)

TIPRANKS
·
28 Feb

Milestone Pharmaceuticals Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
28 Feb

DONNA KARAN CASHMERE MIST INTRODUCES A NEW CHAPTER FOR SPRING 2025, FEATURING IMAAN HAMMAM IN A CAPTIVATING CAMPAIGN

PR Newswire
·
28 Feb

Milestone Pharmaceuticals Gets Notice of Allowance for US Patent on Etripamil Nasal Spray

MT Newswires Live
·
19 Feb

BRIEF-Milestone Pharmaceuticals Inc Receives Notice Of Allowance On New U.S. Patent For Etripamil

Reuters
·
19 Feb

Milestone receives notice of allawance from USPTO on etripamil nasal spray

TIPRANKS
·
19 Feb

Milestone Pharmaceuticals Inc: Receives Notice of Allowance on New U.S. Patent for Etripamil

THOMSON REUTERS
·
19 Feb

Milestone® Pharmaceuticals Notice of Allowance on New U.S. Patent for Etripamil

GlobeNewswire
·
19 Feb